Pasar al contenido principal

MIGRACION Y DIFERENCIACION DE LAS SUBPOBLACIONES DE CELULAS DENDRITICAS Y MONOCITOS EN LA MUCOSA INTESTINAL DE PACIENTES CON ENFERMEDAD INFLAMAMTORY INTESTINAL

PID2019-104218RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment

  • Ugalde Triviño, Lola
  • Molina Jiménez, Francisca
  • H. Vázquez, Juan
  • Relaño Rupérez, Carlos
  • Arias González, Laura
  • Casabona, Sergio
  • Pérez Fernández, María Teresa
  • Martín Domínguez, Verónica
  • Fernández Pacheco, Jennifer
  • Lucendo, Alfredo J.
  • Bernardo, David
  • Santander, Cecilio
  • Majano Rodríguez, Pedro Lorenzo
Objectives. The aim of the study was to characterize the circulating immunome of patients with EoE before and after proton pump inhibitor (PPI) treatment in order to identify potential non-invasive biomarkers of treatment response. Methods. PBMCs from 19 healthy controls and 24 EoE patients were studied using a 39-plex spectral cytometry panel. The plasmacytoid dendritic cell (pDC) population was differentially characterized by spectral cytometry analysis and immunofluorescence assays in esophageal biopsies from 7 healthy controls and 13 EoE patients. Results. Interestingly, EoE patients at baseline had lower levels of circulating pDC compared with controls. Before treatment, patients with EoE who responded to PPI therapy had higher levels of circulating pDC and classical monocytes, compared with non-responders. Moreover, following PPI therapy pDC levels were increased in all EoE patients, while normal levels were only restored in PPI-responding patients. Finally, circulating pDC levels inversely correlated with peak eosinophil count and pDC count in esophageal biopsies. The number of tissue pDCs significantly increased during active EoE, being even higher in non-responder patients when compared to responder patients pre-PPI. pDC levels decreased after PPI intake, being further restored almost to control levels in responder patients post-PPI. Conclusions. We hereby describe a unique immune fingerprint of EoE patients at diagnosis. Moreover, circulating pDC may be also used as a novel non-invasive biomarker to predict subsequent response to PPI treatment.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract

  • Fernández-Tomé, Samuel
  • Indiano-Romacho, Pedro
  • Mora-Gutiérrez, Irene
  • Pérez-Rodríguez, Leticia
  • Ortega Moreno, Lorena
  • Marin, Alicia C.
  • Baldan-Martin, Montserrat
  • Moreno-Monteagudo, J. A.
  • Santander, Cecilio
  • Chaparro, María
  • Hernández-Ledesma, Blanca
  • Gisbert, Javier P.
  • Bernardo, David
[Introduction]: Lunasin is a soybean bioactive peptide with a variety of beneficial properties against chronic disorders. However, its effect in human primary intestinal cells remains unknown. Hence, this study aims to characterize its ex vivo biological activity in the human intestinal mucosa. [Methods and Results]: Human intestinal biopsies, obtained from healthy controls, are ex vivo conditioned with lunasin both in the presence/absence of lipopolysaccharide (LPS). Peptide maintains its stability during biopsy culture by HPLC-MS/MS analysis. Lunasin is bioactive in the human mucosa, as it induces IL-1β, TNF-α, IL-17A, CCL2, and PGE2/COX-2 gene expression together with an increased expression of tolerogenic IL-10 and TGFβ, while it also downregulates the expression of iNOS and subunit p65 from NF-κB. Indeed, lunasin also abrogates the LPS-induced pro-inflammatory response, downregulating IL-17A, IFNγ, and IL-8 expression, and inducing IL-10 and TGFβ expression. These results are also mirrored in the cell-free culture supernatants at the protein level by Multiplex. Moreover, lunasin further induces a regulatory phenotype and function on human intestinal conventional dendritic cell and macrophage subsets as assessed by flow cytometry. [Conclusions]: We hereby have characterized lunasin as an immunomodulatory peptide with potential capacity to prevent immune and inflammatory-mediated disorders in the human gastrointestinal tract., This work was supported by the Spanish Ministry of Economy (SAF2014-56642-JIN), the Spanish Ministry of Health (PIE13/00041), the Spanish Ministry of Science, Innovation and Universities (AGL2015-66886-R, PID2019-104218RB-I00), and the Community of Madrid (Consejería de Educación, Juventud y Deporte, Programa de Garantía Juvenil 2015 and 2016). S.F.T. is currently funded by the Instituto de Salud Carlos III (Sara Borrell fellowship CD17/00014). L.O.M. is funded by the Community of Madrid (BMD-5800). D.B. is funded by the Spanish Ministry of Science (RYC-2017-21606).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A review on the extraction and processing of natural source-derived proteins through eco-innovative approaches

  • Franca-Oliveira, Giselle
  • Fornari, Tiziana
  • Hernández-Ledesma, Blanca
This article belongs to the Special Issue Extraction and Fractionation Processes of Functional Components in Food Engineering., In addition to their nutritional and physiological role, proteins are recognized as the major compounds responsible for the rheological properties of food products and their stability during manufacture and storage. Furthermore, proteins have been shown to be source of bioactive peptides able to exert beneficial effects on human health. In recent years, scholarly interest has focused on the incorporation of high-quality proteins into the diet. This fact, together with the new trends of consumers directed to avoid the intake of animal proteins, has boosted the search for novel and sustainable protein sources and the development of suitable, cost-affordable, and environmentally friendly technologies to extract high concentrations of valuable proteins incorporated into food products and supplements. In this review, current data on emergent and promising methodologies applied for the extraction of proteins from natural sources are summarized. Moreover, the advantages and disadvantages of these novel methods, compared with conventional methods, are detailed. Additionally, this work describes the combination of these technologies with the enzymatic hydrolysis of extracted proteins as a powerful strategy for releasing bioactive peptides., This research was funded by the Spanish Ministry of Science and Innovation, projects PID2019-104218RB-I00/AEI/2015-66886R and PID2019-110183RB-C22/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cocoa (Theobroma cacao L.) seed-derived peptides reduce blood pressure by interacting with the catalytic site of the angiotensin-converting enzyme

  • Coronado-Cáceres, Luis Jorge
  • Hernández-Ledesma, Blanca
  • Mojica, Luis
  • Quevedo-Corona, Lucía
  • Rabadán-Chávez, Griselda
  • Castillo-Herrera, Gustavo Adolfo
  • Lugo-Cervantes, Eugenia
This article belongs to the Special Issue Current Research on Antioxidant, Anti-inflammatory and Anti-obesity Potential of Food Extracts., This study aimed at determining the effect of cocoa proteins (CP) on the blood pressure, using in silico, in vitro and in vivo approaches. The in silico assay showed 26 Criollo cocoa peptides with alignment in the Blast® analysis. Peptide sequences ranged from 6 to 16 amino acids, with molecular weight ranging from 560.31 to 1548.76 Da. The peptide sequences LSPGGAAV, TSVSGAGGPGAGR, and TLGNPAAAGPF showed the highest theoretical affinity with −8.6, −5.0, and −10.2 kcal/mol, for the angiotensin-converting enzyme (ACE), renin, and angiotensin II type 1 receptor (AT1-R), respectively. The Criollo CP hydrolysates (CPH) presented in vitro ACE inhibitory activity with an IC50 value of 0.49 mg/mL. Furthermore, the orogastric administration of 150 mg CP/kg/day in rats fed a high-fat (HF) diet (HF + CP group) showed a significant decrease in systolic blood pressure (SBP) by 5% (p < 0.001) and diastolic blood pressure (DBP) by 7% (p < 0.001) compared with the HF group. The human equivalent dose (HED) of CP for an adult (60 kg) is 1.45 g per day. These results suggest that the consumption of CP could reduce blood pressure by blocking ACE, and could be used as an ingredient in the elaboration of antihypertensive functional foods., This study was funded by projects 2017-02-291417 “Development of technological innovations for the sustainable integrated management of the Cocoa crop (Theobroma cacao L.) in Mexico” (CONACYT-SAGARPA), PID2019-104218RB-I00/AEI/2015-66886R (Ministry of Science and, Innovation, Spain), and SIP20195713 (Instituto Politécnico Nacional, IPN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

New Advances in the Research of Antioxidant Food Peptides

  • Amigo, Lourdes
  • Hernández-Ledesma, Blanca
This book is a printed edition of the Special Issue New Advances in the Research of Antioxidant Food Peptides that was published in Foods., Edited by: Lourdes Amigo and Blanca Hernández-Ledesma, During cell metabolism, oxygen is partially reduced to reactive oxygen species (ROS) that play a physiological role in cellular processes, including proliferation, cell cycle and death, and signal transduction. However, their high reactivity makes ROS responsible for oxidation of lipid, proteins, and DNA, causing damaging effects on vital tissues. These destructive effects can be counteracted by endogenous antioxidant defenses. Nevertheless, an imbalance between the production of ROS and the ability of defenses to detoxify the organism provokes a status of oxidative stress. This status and its subsequent damages to vital cellular components have been associated with numerous severe chronic disorders, such as cardiovascular and neurodegenerative diseases, diabetes, metabolic syndrome, intestinal inflammatory diseases, and cancer. In addition, oxidation reactions are responsible for food deterioration during processing and storage. In spite of their remarkable effectiveness, the endogenous antioxidant systems are not sufficient and humans are dependent on dietary antioxidants to maintain ROS concentrations at low levels. A number of natural antioxidants have been revealed as potential preventative/therapeutic agents against oxidative stress. Among them, peptides from animal and vegetal food sources have attracted attention because of the large evidence on their in vitro antioxidant properties. In addition to their potential as safer alternatives to synthetic antioxidants used to prevent oxidative reactions in foods, antioxidant peptides can also act by reducing the risk of numerous oxidative stress-associated diseases. Furthermore, peptides can act synergistically with nonpeptide antioxidants, enhancing their protective effect., This work was funded by project AGL2015-66886-R from the Spanish Ministry of Science and Innovation (MICIU) and PID2019-104218RB-I00 (CSIC)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Differential effects of Anti-TNFα and Anti-α4β7 drugs on circulating dendritic cells migratory capacity in inflammatory bowel disease

  • Soleto, Irene
  • Fernández-Tomé, Samuel
  • Mora-Gutiérrez, Irene
  • Baldan-Martin, Montserrat
  • Ramírez, Cristina
  • Santander, Cecilio
  • Moreno-Monteagudo, J. A.
  • Casanova, María José
  • Casals, Fernando
  • Casabona, Sergio
  • Becerro, Irene
  • Chaparro, María
  • Bernardo, David
  • Gisbert, Javier P.
Inflammatory bowel disease (IBD) is an idiopathic and chronic disorder that includes ulcerative colitis (UC) and Crohn’s disease (CD). Both diseases show an uncontrolled intestinal immune response that generates tissue inflammation. Dendritic cells (DCs) are antigen-presenting cells that play a key role in tolerance maintenance in the gastrointestinal mucosa. Although it has been reported that DC recruitment by the intestinal mucosa is more prominent in IBD patients, the specific mechanisms governing this migration are currently unknown. In this study, the expression of several homing markers and the migratory profile of circulating DC subsets towards intestinal chemo-attractants were evaluated and the effect of biological drugs with different mechanisms of action, such as anti-TNFα or anti-integrin α4β7 (vedolizumab), on this mechanism in healthy controls (HCs) and IBD patients was also assessed. Our results revealed that type 2 conventional DCs (cDC2) express differential homing marker profiles in UC and CD patients compared to HCs. Indeed, integrin β7 was differentially modulated by vedolizumab in CD and UC. Additionally, although CCL2 displayed a chemo-attractant effect over cDC2, while biological therapies did not modulate the expression of the homing markers, we paradoxically found that anti-TNF-treated cDC2 increased their migratory capacity towards CCL2 in HCs and IBD. Our results therefore suggest a key role for cDC2 migration towards the intestinal mucosa in IBD, something that could be explored in order to develop novel diagnostic biomarkers or to unravel new immunomodulatory targets in IBD., This study has been funded through the Instituto de Salud Carlos III (Sara Borrell fellowships, CD17/00014; CD21/00014), Asociación Española de Gastroenterología (Beca del Grupo Joven), Programa Estratégico Instituto de Biología y Genética Molecular (IBGM Junta de Castilla y León. Ref. CCVC8485), Plan Nacional (PID2019-104218RB-I00) from the Spanish Government, Janssen and MSD.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulatory effects of a Lunasin-enriched soybean extract on immune response and oxidative stress-associated biomarkers

  • Paterson, Samuel
  • Fernández-Tomé, Samuel
  • Hernández-Ledesma, Blanca
This article belongs to the Proceedings of The 2nd International Electronic Conference on Nutrients., The immune system, inflammatory, and oxidative processes are involved in the pathogenesis of a variety of chronic diseases. Soybean lunasin has emerged as one of the most promising food-derived peptides with a positive impact on health. A soybean extract enriched in lunasin (LES) was obtained and characterized, evaluating its behavior under simulated gastrointestinal conditions. Besides its in vitro radical scavenging capacity, the effects of LES on cell viability, phagocytic capacity, and levels of oxidative stress and inflammation-associated biomarkers were investigated in macrophages RAW 264.7. Different LES doses and treatment times were assayed. After extraction with an aqueous solvent, an enrichment with soluble proteins and small peptides, such as lunasin, was achieved. Lunasin was detected at the end of the simulated digestion, indicating its partial resistance to this process. LES showed radical scavenging activity. Moreover, at low doses, LES reduced reactive oxygen species (ROS) in macrophages, while an oxidizing effect was observed at the highest concentration. LES exerted an immunomodulatory action, increasing the production of nitric oxide (NO) in a dose- and time-dependent manner, and the phagocytic activity at short treatment times. LES also had a modulatory action on the secretion of pro-inflammatory (interleukin IL-6) and anti-inflammatory (IL-10) cytokines., This research was funded by the Spanish Ministry of Science and Innovation, project PID2019-104218RB-I00/AEI/2015-66886R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

  • Martín-Adrados, Beatriz
  • Wculek, Stefanie K.
  • Fernández-Bravo, Sergio
  • Torres-Ruiz, Raúl
  • Valle-Noguera, Ana
  • Gómez-Sánchez, María José
  • Hernández-Walias, José Carlos
  • Moraes Ferreira, Frederico
  • Corraliza, Ana María
  • Sancho, David
  • Esteban, Vanesa
  • Rodríguez-Perales, Sandra
  • Cruz-Adalia, Aránzazu
  • Nakaya, Helder I.
  • Salas, Azucena
  • Bernardo, David
  • Campos-Martín, Yolanda
  • Martínez-Zamorano, Elena
  • Muñoz-López, Diego
  • Gómez del Moral, Manuel
  • Cubero, Francisco Javier
  • Blumberg, Richard S.
  • Martínez-Naves, Eduardo
[Introduction]: The Unfolded Protein Response, a mechanism triggered by the cell in response to Endoplasmic reticulum stress, is linked to inflammatory responses. Our aim was to identify novel Unfolded Protein Response-mechanisms that might be involved in triggering or perpetuating the inflammatory response carried out by the Intestinal Epithelial Cells in the context of Inflammatory Bowel Disease. [Methods]: We analyzed the transcriptional profile of human Intestinal Epithelial Cell lines treated with an Endoplasmic Reticulum stress inducer (thapsigargin) and/or proinflammatory stimuli. Several genes were further analyzed in colonic biopsies from Ulcerative Colitis patients and healthy controls. Lastly, we generated Caco-2 cells lacking HMGCS2 by CRISPR Cas-9 and analyzed the functional implications of its absence in Intestinal Epithelial Cells. [Results]: Exposure to a TLR ligand after thapsigargin treatment resulted in a powerful synergistic modulation of gene expression, which led us to identify new genes and pathways that could be involved in inflammatory responses linked to the Unfolded Protein Response. Key differentially expressed genes in the array also exhibited transcriptional alterations in colonic biopsies from active Ulcerative Colitis patients, including NKG2D ligands and the enzyme HMGCS2. Moreover, functional studies showed altered metabolic responses and epithelial barrier integrity in HMGCS2 deficient cell lines. [Conclusion]: We have identified new genes and pathways that are regulated by the Unfolded Protein Response in the context of Inflammatory Bowel Disease including HMGCS2, a gene involved in the metabolism of Short Chain Fatty Acids that may have an important role in intestinal inflammation linked to Endoplasmic Reticulum stress and the resolution of the epithelial damage., This work was supported by grants from Ministerio de Ciencia e Innovación (MCIN) from Spain [SAF2016-78711R and PID202-11794 to EM-N and FJC]; Comunidad de Madrid [B2017/BMD-3727 to EM-N and FJC]; Comunidad de Madrid (REACT-UE, ANTICIPA-CM Ref. PR38/21-24) to E.M-N and HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679 to FJC the European Union’s Horizon 2020 research and innovation program [ERC-2016-Consolidator Grant 725091 to DS]; MCIN/AEI/10.13039/501100011033 [PID2019-108157RB to DS]; la Caixa Foundation (ID 100010434) [LCF/BQ/PR20/11770008 to SW]; Instituto de Salud Carlos III (ISCIII) [PI18/00348 to VE]; ISCIII [PI21/01641 to RT-R]; Spanish National Research and Development Plan, ISCIII and FEDER [PI17/02303 and PI20/01837 to SR-P]; Proyecto Desarrollo Tecnológico [DTS19/00111 to SR-P], AEI/MICIU EXPLORA Project [BIO2017-91272-EXP to SR-P]; Programa Estratégico Instituto de Biología y Genética Molecular (IBGM), Junta de Castilla y León (CCVC8485) [PID2019-104218RB-I00 to DB]; NIH [DK088199 to RB] and Universidad Complutense de Madrid (UCM 920631) [CT42/18-CT43/18 and EB15/21 to BM-A]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Top-of-The-Art cytometry as a novel tool to aid in lung cancer immunotherapy

  • Mondelo-Macía, Patricia
  • León-Mateos, Luis
  • Bernardo, David
  • Díaz-Peña, Roberto
Non-small cell lung cancer (NSCLC) is perhaps the cancer type that better exemplifies the transition to precision medicine for cancer. Indeed, around 15% of patients with advanced NSCLC display genomic alterations in EGFR, ALK, ROS1, BRAF or MET so targeted therapies have improved their survival outcomes (1). Not in vain, immunotherapy has been one of the great advances for the treatment of advanced tumours, mostly NSCLC. The development of immune checkpoint inhibitors (ICIs) has resulted in a paradigm shift as we can now modulate the patient´s immune system to target cancer cells. Immune checkpoint molecules, such as programmed cell death protein 1 (PD-1), its ligand (PD-L1), and cytotoxic lymphocyte-associated protein 4 (CTLA-4), are proteins that contribute to the regulation of the immune system and prevent it from attacking healthy cells in the body. By targeting these proteins, ICIs can “release the brakes” on the immune system, allowing the immune system to target cancer cells more effectively. Hence, immunotherapy has significantly improved the survival outcomes of patients with advanced NSCLC, but unfortunately, not all patients benefit from this treatment approach. There is therefore a real need to discover novel biomarkers to identify the specific NSCLC patients who will respond to ICIs, namely, utilizing personalized medicine to maximize the benefits of the therapy while minimizing its side effects., This work was supported by the Miguel Servet contract, funded by the ISCIII and co-funded by the European Union (No. CP21/00003 to R Díaz-Peña), the Programa Estratégico Instituto de Biología y Genética Molecular (IBGM Junta de Castilla y León. Ref. CCVC8485 to D Bernardo), Spanish Ministry of Science (No. PID2019-104218RB-I00 to D Bernardo), the European Commission-NextGenerationEU (Regulation EU 2020/2094 to D Bernardo), and CSIC’s Global Health Platform (PTI Salud Global to D Bernardo)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Plasma levels of intestinal fatty-acid binding protein (I-FABP), abdominal distension and hydrogen concentration after lactitol small intestinal bacterial overgrowth (SIBO) test

  • Maroto, Marcos
  • Fiz-López, Aida
  • Pastor, Raquel
  • Bernardo, David
  • Garrote, José Antonio
  • Arranz, Eduardo
  • Fernández-Salazar, Luis
Breath tests with glucose, lactulose or lactitol are useful for diagnosis of small intestinal bacterial overgrowth (SIBO). Nevertheless, they have suboptimal sensitivity and specificity and, indeed, are positive in a considerable number of patients with irritable bowel syndrome (IBS). The complexity in the management of patients with functional intestinal disorders and the availability of these tests are leading to frequent diagnoses of SIBO. Intestinal Fatty-Acid Binding protein (I-FABP) is a protein present in the cytosol of intestinal epithelial cells. Its plasmatic levels have been related to different enteropathies and, therefore, could be a marker of early intestinal damage with unconfirmed clinical utility. Hence, we have studied the plasmatic I-FABP level of patients who are requested a lactitol test to confirm SIBO and related it to clinical and laboratory characteristics and SIBO test results., This work was funded by the Spanish Ministry of Science (PID2019-104218RB-I00) and by the Programa Estratégico Instituto de Biología y Genética Molecular (IBGM), Junta de Castilla y León (CCVC8485). DB is part of the CSIC’s Global Health Platorm (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment

  • Ugalde-Triviño, Lola
  • Molina-Jiménez, Francisca
  • Hernández Vázquez, Juan
  • Relaño-Rupérez, Carlos
  • Arias-Gonzalez, L.
  • Casabona, Sergio
  • Pérez-Fernández, María Teresa
  • Martín-Domínguez, Verónica
  • Fernández-Pacheco, Jennifer
  • Lucendo, A. J.
  • Bernardo, David
  • Santander, Cecilio
  • Majano, Pedro
[Objectives]: The aim of the study was to characterize the circulating immunome of patients with EoE before and after proton pump inhibitor (PPI) treatment in order to identify potential non-invasive biomarkers of treatment response., [Methods]: PBMCs from 19 healthy controls and 24 EoE patients were studied using a 39-plex spectral cytometry panel. The plasmacytoid dendritic cell (pDC) population was differentially characterized by spectral cytometry analysis and immunofluorescence assays in esophageal biopsies from 7 healthy controls and 13 EoE patients., [Results]: Interestingly, EoE patients at baseline had lower levels of circulating pDC compared with controls. Before treatment, patients with EoE who responded to PPI therapy had higher levels of circulating pDC and classical monocytes, compared with non-responders. Moreover, following PPI therapy pDC levels were increased in all EoE patients, while normal levels were only restored in PPI-responding patients. Finally, circulating pDC levels inversely correlated with peak eosinophil count and pDC count in esophageal biopsies. The number of tissue pDCs significantly increased during active EoE, being even higher in non-responder patients when compared to responder patients pre-PPI. pDC levels decreased after PPI intake, being further restored almost to control levels in responder patients post-PPI., [Conclusions]: We hereby describe a unique immune fingerprint of EoE patients at diagnosis. Moreover, circulating pDC may be also used as a novel non-invasive biomarker to predict subsequent response to PPI treatment., PM and CS are supported by grants PI17/0008 and ISCIII-Proteored 2019 of Instituto de Salud Carlos III (ISCIII, Spain) and co-funded by Fondo Europeo de Desarrollo Regional (FEDER). CS is also funded by Asociación Española de Gastroenterología (AEG) 2019 grant. DB is funded through the Spanish Ministry of Science [PID2019-104218RB-I00], Programa Estratégico Instituto de Biología y Genética Molecular (IBGM Junta de Castilla y León. Ref. CCVC8485) and the European Commission –NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform. LU-T is recipient of an INVESTIGO contract from Comunidad de Madrid (09-PIN1-00015.6/2022) partly funded by the European Social Fund, NextGenerationEU, and Recovery, Transformation and Resilience Plan. CR-R is recipient of an INVESTIGO contract from Ministry of Labor and Social Economy, the national public employment service (SEPE) (INVESTIGO Exp. 2022‐C23.I01.P03. S0020‐0000031) partly funded by the European Social Fund, NextGenerationEU, and Recovery, Transformation and Resilience Plan., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Complex immune network and regional consistency in the human gastric mucosa revealed by high-resolution spectral cytometry

  • Prado-Santos, Ángel de
  • Cal-Sabater, Paloma de la
  • Fiz-López, Aida
  • Izquierdo, Sandra
  • Corrales, Daniel
  • Pérez-Cózar, Francisco
  • Hernández Vázquez, Juan
  • Arribas, Elisa
  • Pérez-Segurado, Cándido
  • Martín-Muñoz, Álvaro
  • Garrote, José Antonio
  • Arranz, Eduardo
  • Marañón, Concepción
  • Cuesta-Sancho, Sara
  • Fernández-Salazar, Luis
  • Bernardo, David
The immune cellular landscape from the gastric mucosa remains largely unknown despite its relevance in several inflammatory conditions. Human gastric biopsies were obtained from the antrum, body and incisura from 10 individuals to obtain lamina propria mononuclear cells that were further characterized by spectral cytometry. Phenotypic hierarchical analyses identified a total of 52 different immune cell subsets within the human gastric mucosa revealing that T-cells (> 60%) and NK cells (> 20%) were the main populations. Within T-cells, CD4+ and CD8+ were equally represented with both subsets displaying mainly a memory and effector phenotype. NK cells, on the contrary, were largely of the early phenotype. No regional differences were observed for any subsets among the 3 locations. Following unsupervised analysis, a total of 82 clusters were found. Again, no differences were observed amongst locations although a great degree of inter-individual variability was found, largely influenced by the presence of H. pylori infection and dyspepsia. We have unraveled the human gastric immune cellular subset composition and a unique interindividual immune fingerprint with no inter-regional variations., This work was funded by the Spanish Ministry of Science (PID2019-104218RB-I00) and the Unit of Excellence Institute of Biomedicine and Molecular Genetics, Junta de Castilla y Leon (CCVC8485). DB is also a member of the CSIC´s Global health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

State-of-the-art cytometry in the search of novel biomarkers in digestive cancers

  • Castro, Carolina G. de
  • Hierro, Alejandro G. del
  • Hernández Vázquez, Juan
  • Bernardo, David
Despite that colorectal and liver cancer are among the most prevalent tumours in the world, the identification of non-invasive biomarkers to aid on their diagnose and subsequent prognosis is a current unmet need that would diminish both their incidence and mortality rates. In this context, conventional flow cytometry has been widely used in the screening of biomarkers with clinical utility in other malignant processes like leukaemia or lymphoma. Therefore, in this review, we will focus on how advanced cytometry panels covering over 40 parameters can be applied on the study of the immune system from patients with colorectal and hepatocellular carcinoma and how that can be used on the search of novel biomarkers to aid or diagnose, prognosis, and even predict clinical response to different treatments. In addition, these multiparametric and unbiased approaches can also provide novel insights into the specific immunopathogenic mechanisms governing these malignant diseases, hence potentially unravelling novel targets to perform immunotherapy or identify novel mechanisms, rendering the development of novel treatments. As a consequence, computational cytometry approaches are an emerging methodology for the early detection and predicting therapies for gastrointestinal cancers., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. CC and AH are currently funded by the Spanish Association Against Cancer (Asociación Española Contra el Cáncer—AECC). The lab is currently funded by the Spanish Ministry of Science (PID2019–104218RB-I00), Programa Estratégico Instituto de Biología y Genética Molecular (IBGM Junta de Castilla y León. Ref. CVC8485), and the European Commission—NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed